Skip links

Our Story

PharmaACE operates at the intersection of science, data, technology and business strategy. Our consultants provide clients with innovative solutions based on deep industry insights, analytical expertise, and an unbiased perspective.

With our focus on data analytics and modelling, we knew we had to deal with the unmet need around tools and technologies.

Our IT journey, therefore, started hand in hand with our consulting practice. Today, our technology experts not only create customized platforms and tools, but also work on data analytics, using Big Data and Machine Learning.

Homepage-v3

Our Teams

The talent in our teams spans across diverse backgrounds such as our qualified physicians, pharmacists, engineers and data scientists

Homepage-v3

Our Clients

Our selective and elite client base includes established, multinational bio-pharmaceutical leaders and innovators, as well as entrepreneurial firms on the cutting edge of science

Homepage-v3

Major Therapeutic Areas

Our expertise spans across multiple therapy areas: Oncology, Immuno-science, CNS, Cardiovascular and Metabolic diseases, and Rare Diseases, and many others.

Our Solutions

Our Analytics & Consulting services include

analytics & consulting services
technology services

Our Technology services include

Why Us?

Homepage-v3

From Concept to Execution

The majority of our projects go beyond strategic recommendations and deliver real time implementation of tools and capabilities.

Homepage-v3

Simplified Value-Driven Solutions

Solutions to all business needs under one roof. From day-to-day tactical analytics to long-term strategic plans, our comprehensive solutions platforms can solve any business problem.

Homepage-v3

Tailored Approach

It’s no longer necessary to take a one-size-fits-all approach. We identify and adapt based on the need of the project

Homepage-v3

Client Value

Partnering with clients to build lasting value is an exciting and rewarding endeavor. We learn from our clients and explore new technologies to optimize our offerings and deliverables.

Homepage-v3

People and Culture

Our seasoned professionals have the attitude for getting it right the first time. Our diverse, passionate and creative teams are experienced enough to understand the nature of challenges and opportunities they could encounter in various client projects

Homepage-v3

Trust and Relationships

We conduct our business with along term outlook providing value on a consistent basis. Our reputation for delivering cost effective superior services and exceptional results has led to long lasting relationships & great trust with our clients

Homepage-v3
6500+
Projects till date
Homepage-v3
150+
Employees globally
Homepage-v3
15+
Therapy Areas
Homepage-v3
6500+
Projects till date
Homepage-v3
150+
Employees globally
Homepage-v3
15+
Therapy Areas
pharmaace-map

USA

100 Overlook Center,
Floor 2, Princeton,
NJ, 08540
Tel: +1 609 375 2125
Fax: +1 609 375 2001

Canada

PharmaACE INC
5770 Hurontario Street
Suite 103
Mississauga ON L5R 3G5

Germany

PharmaACE GmbH,
Lyoner Str. 14, 60528
Frankfurt am Main

India

IT-9 Qubix Business Park,
Blueridge,
Hinjewadi Phase 1,
Pune, MH, 411057
Tel: +91 20 6799 2999

India

IT-5 Qubix Business Park,
Blueridge,
Hinjewadi Phase 1,
Pune, MH, 411057
Tel: +91 20 6799 2999
Contact Us
After the closure of the original Silk Road, the online drug trade did not stop, which, however, was predictable. There are copies of the site: Silk Road 2.0, Silk Road 3.0. However, they did not last long either. Today, Silk Road 3.1 can be found on the darknet bestdarknet. The European Union Police Services Internet Organized Threat Assessment report says that in 2017, intelligence agencies closed at least nine major darknet sites selling illegal goods, including AlphaBay and Hansa. However, this has led to the expansion of smaller platforms. For example, on the English-language Dream Market, the traffic of visitors increased by 20%. Major markets such as Wall Street, TradeRoute and cocaine for sale and T-Chka / P-int saw attendance rise by 290%, 475% and 840%, respectively.